Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopentane SCHEMBL4760575 | 1.00 | — | — | |
| Propanol SCHEMBL3454454 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Propanol SCHEMBL29043138 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Cycloheptane SCHEMBL5575860 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Propanol SCHEMBL3834016 | 1.00 | — | — | |
| Propanol SCHEMBL3455203 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Propanol SCHEMBL23149256 | 1.00 | — | — | |
| Cyclohexane SCHEMBL3455153 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Cyclooctane SCHEMBL5572396 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 | |
| Cyclopentane SCHEMBL3456038 | 1.00 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118222171-A | Nanometer stamping adhesive for improving adhesive force of glass-based circuit and circuit manufacturing method based on glass substrate | 深圳市百柔新材料技术有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-113035408-B | Solar cell grid line slurry and preparation method thereof, and solar cell | 深圳市百柔新材料技术有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-103962091-A | Method for separating EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) by using silver ion modified amino silica gel | UNIV DALIAN POLYTECHNIC | 2014-08-06 | — | — | CN | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4593639-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250186960-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-3888782-B1 | COATED MICROCAPSULES | NOXELL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250177298-A1 | EMULSIONS AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-05 | — | — | US | disclosed |
| WO-2025109106-A1 | CORE-SHELL MICROCAPSULES | XAMPLA Ltd. (GB) | 2025-05-30 | — | — | WO | disclosed |
| WO-1999016801-A1 | GLYOXYLIC COMPOUND COMPRISING ONE OR MORE ACTIVE INGREDIENT | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1999016804-A1 | GLYOXYLIC COMPOUND COMPRISING ONE OR MORE ACTIVE INGREDIENT | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-08 | — | — | WO | disclosed |
| US-5716458-A | CLEANING BY VAPORIZATION, CONDENSATION OF AN AZEOTROPIC LIQUID MIXTURE; HALOGEN-FREE | NIKON CORPORATION (JP) | 1998-02-10 | — | — | US | disclosed |
| US-5147586-A | Hydrocarbon and solvent, air pollution control | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-15 | — | — | US | disclosed |
| US-4874474-A | RECTIFICATION, SEPARATION, DISTILLATION, AND RECTIFICATION | SNAMPROGETTI S.P.A. (IT) | 1989-10-17 | — | — | US | disclosed |
| EP-0057415-B1 | POLYESTER RESIN COMPOSITION | TEIJIN LIMITED (JP) | 1987-04-29 | — | — | EP | disclosed |
| US-4536531-A | Polyester resin composition | TEIJIN LIMITED (JP) | 1985-08-20 | — | — | US | disclosed |
| EP-0057415-A2 | Polyester resin composition | TEIJIN LIMITED (JP) | 1982-08-11 | — | — | EP | disclosed |
| US-3985719-A | Process for the controlled alcoholysis of ethylene-vinyl ester interpolymers | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | ALDH1A1 4813/4885SMN1; SMN2 4205/4885TSHR 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.